RAC1 and cancer: The present study revealed that pathogenic IDH1 mutation contributes to cancer aggressiveness via prompting cellular food-seeking, motility, chemotaxis, and endocytosis, which resulted from the augmented mTORC2/Rac1 pathway and concomitant cytoskeleton mobilization.